Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Cap table

Cullinan Therapeutics, Inc.

Cap table

Built by 6ix from Cullinan Therapeutics, Inc.’s releases · as of Nov 4, 2026

Common shares
64,920,924
Fully diluted
64,920,924

Fully diluted

LineSharesAs of
Common shares64,920,924Nov 4, 2026

Share count over time

CountShares
Nov 4, 202664,920,924